Chapter 1.GLOBAL ON-PREMISES MOLECULAR IMAGING MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.GLOBAL ON-PREMISES MOLECULAR IMAGING MARKET – Executive Summary

2.1. Market Size & Forecast – (2024 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2024 - 2030

      2.3.2. Impact on Supply – Demand

Chapter 3.GLOBAL ON-PREMISES MOLECULAR IMAGING MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.GLOBAL ON-PREMISES MOLECULAR IMAGING MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. GLOBAL ON-PREMISES MOLECULAR IMAGING MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6.GLOBAL ON-PREMISES MOLECULAR IMAGING MARKET – By Modality

6.1. Positron Emission Tomography (PET)

6.2. Positron Emission Tomography- Computed Tomography (PET-CT)

6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

6.4. Single Photon Emission Computed Tomography (SPECT)

6.5. Software

6.5.1. On-Premises Solutions

6.5.2. Cloud-Based Solutions

6.7. Magnetic Resonance

6.9. Molecular Ultrasound Imaging

Chapter 7.GLOBAL ON-PREMISES MOLECULAR IMAGING MARKET– By Application

7.1.  Cardiology

7.2. Oncology

7.3. Gastrointestinal Disorders

7.4. Neurology Disorders

7.5. Others

Chapter 8.GLOBAL ON-PREMISES MOLECULAR IMAGING MARKET – By End-User

8.1. Hospitals

8.1.1. 500+ Beds

8.1.2. 200-499 Beds

8.1.3. Less than 200 Beds

8.2. Ambulatory Surgical Centres

8.3. Diagnostic Centres

Chapter 9.GLOBAL ON-PREMISES MOLECULAR IMAGING MARKET – By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. The Middle East

9.6. Africa

Chapter 10.GLOBAL ON-PREMISES MOLECULAR IMAGING MARKET – Key Players

10.1. Hermes Medical Solutions

10.2. Bruker Corporation

10.3. GE Company

10.4. Fujifilm Holdings Corp.

10.5. Koninklijke Philips N.V.

10.6. Siemens AG

10.7. Toshiba Medical System Corp.

10.8. Mirada Medical Limited

10.9. Carestream Health, Inc.

10.10. Esaote SpA

10.11. Positron Corporation

10.12. Medisco Ltd.

10.13. Hitachi Medical Corp.

10.14. MIM Software Inc.